A high-fat diet may combat low platelet counts in the blood caused by chemotherapy, according to preliminary research, which suggests that a ketogenic eating plan may be a nontoxic, low-cost and high-benefit addition to cancer ...
A phase I clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with end-stage cancers. The drug stalled the growth of tumors in the five people in the ...
Dec 22, 2022
0
28
Clinical trials in adults conducted within the National Cancer Institute's (NCI's) National Clinical Trials Network (NCTN) over the last four decades are estimated to have extended the lives of patients with cancer in the ...
Dec 20, 2022
0
67
Breast cancer patients who paused their endocrine therapy to try to get pregnant experienced short-term rates of breast cancer recurrence similar to women who did not pause therapy for pregnancy, and many went on to conceive ...
Dec 9, 2022
0
5
A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models ...
Dec 6, 2022
0
11
A short, simple and safe drug treatment developed at Tel Aviv University reduced the risk of the spread of cancer metastases after surgery to remove the primary tumor—according to the first clinical study of its kind conducted ...
Dec 6, 2022
0
155
Researchers at the University of Michigan Rogel Cancer Center and School of Dentistry found that certain drugs can change the fundamental makeup of cancer stem cells in mouse models of mucoepidermoid carcinoma—a lethal ...
Dec 5, 2022
0
45
An interdisciplinary team of researchers led by Indiana University bioengineer Feng Guo has developed a tool that could lead to improved cancer immunotherapy. The prototype platform facilitates automated drug screening and ...
Dec 1, 2022
0
100
Cholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers and approximately 3% of gastrointestinal tumors. While rare, the ...
Nov 29, 2022
0
25
The COVID-19 pandemic has exposed weaknesses in cancer health systems and in the cancer research landscape across Europe, which, if not addressed as a matter of urgency, will set back cancer outcomes by almost a decade. In ...
Nov 16, 2022
0
60
